International Journal of

Diabetes and Clinical ResearchISSN: 2377-3634


 Open Access DOI:10.23937/2377-3634/1410112

Diabetes in Latin America: Prevalence, Complications, and Socio- Economic Impact

L Sinisterra-Loaiza, A Cardelle-Cobas, AG Abraham, MN Calderon, MA Espinoza, LG Gonzalez- Olivares, M Gotteland, A Pazos-Sierra, S San Martin, A Cepeda, JJ Gagliardino and IBEROBDIA Project Group

Article Type: Research Article | First Published: September 28, 2019

To review and update epidemiological data on type 2 diabetes (T2D) in Spain and four Latin American countries: Colombia, Mexico, Chile, and Argentina. Literature was reviewed by a search of PubMed, publications of the Ministry of Health, World Health Organization, International Diabetes Federation, and other public health agencies of each respective country. Of the five countries above, Mexico (13.6%) had the highest prevalence of diabetes, followed by Spain (10.4%). Within these countries, sign...

 Open Access DOI:10.23937/2377-3634/1410111

More Than Just 1200 Foot Care Nurses in America are Needed for 30.3 Million People Who Have Diabetes

Jacqueline E Sharpe, PhD, RN, CHES

Article Type: Commentary | First Published: September 23, 2019

There is an outstanding group of registered nurses who specialized in the care of wounds and working with DFUs. Since there are only about 1200 of them in the US and 30.3 million people who have diabetes, these nurses need some help and that help can come from the community. Looking at the increasing number of people with diabetes and their need to know preventive care information, there is no time better than this for community organizing and community building for health and wellness. One does...

 Open Access DOI:10.23937/2377-3634/1410110

Is it Time to Review the Role of Continuous Glucose Monitoring Systems in Diabetes Management?

Le Minh Quang, MSc, MD

Article Type: Review Article | First Published: September 19, 2019

Hemoglobin A1C (HbA1c) and self-monitoring of blood glucose (SMBG) are widely used as standardized measurements in diabetes management. HbA1c is a measure of the mean blood glucose level over a period of 8-12 weeks. This index is easy to measure, relatively inexpensive and internationally standardized. HbA1c helps to predict the complications, particularly microvascular complications in patients with diabetes. However, because HbA1c represents only an average measure of glucose levels, it does n...

Volume 6
Issue 3